The new vitamin E derivative, ETS-GS, protects against cecal ligation and puncture-induced systemic inflammation in rats

Inflammation

Volumn 35, Issue 2, 2012, Pages 545-553

  Koga, Hironori ^a   Hagiwara, Satoshi ^a   Inomata, Masafumi ^a   Kono, Youhei ^a   Oyama, Yoshimasa ^a   Kai, Shinya ^a   Nishida, Taichi ^a   Noguchi, Takayuki ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Acute inflammation; Lung; MAPK; Sepsis; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL DERIVATIVE; ETS GS; HIGH MOBILITY GROUP B1 PROTEIN; I KAPPA B ALPHA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CYTOKINE RELEASE; IN VITRO STUDY; LUNG EDEMA; MACROPHAGE; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; RAT; SEPSIS; SEPTIC SHOCK;

ACUTE LUNG INJURY; ANIMALS; CECUM; CELL LINE; EDEMA; HMGB1 PROTEIN; I-KAPPA B PROTEINS; INTERLEUKIN-6; LEUKOCYTES; LUNG; MACROPHAGES; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; OLIGOPEPTIDES; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RANDOM ALLOCATION; RATS; RATS, WISTAR; SEPSIS; SHOCK, SEPTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

MUS; RATTUS; RATTUS NORVEGICUS;

EID: 84863783838     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-011-9344-2     Document Type: Article

References (30)

1. Marshall, J.C. 2001. Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome. Critical Care Medicine 29: S99-S106. (Pubitemid 32681590)
2. Russell, J.A., J. Singer, G.R. Bernard, et al. 2000. Changing pattern of organ dysfunction in early human sepsis is related to mortality. Critical Care Medicine 28: 3405-3411.
3. Riedemann, N.C., R.F. Guo, and P.A. Ward. 2003. The enigma of sepsis. Journal of Clinical Investigation 112: 460-467. (Pubitemid 38056327)
4. Angus, D.C., W.T. Linde-Zwirble, J. Lidicker, et al. 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated cost of care. Critical Care Medicine 29: 1303-1310. (Pubitemid 32641789)
5. Bhatia, M., and S. Moochhala. 2004. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. The Journal of Pathology 202: 145-156. (Pubitemid 38208651)
6. Wang, H., O. Bloom, M. Zhang, et al. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251. (Pubitemid 29329996)
7. Wang, H., J.M. Vishnubhakat, O. Bloom, et al. 1999. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 126: 389-392. (Pubitemid 29382808)
8. Wang, H., H. Yang, C.J. Czura, et al. 2001. HMGB1 as a late mediator of lethal systemic inflammation. American Journal of Respiratory and Critical Care Medicine 164: 1768-1773. (Pubitemid 33152308)
9. Downward, J. 1998. Mechanisms and consequences of activation of protein kinase B/Akt. Current Opinion in Cell Biology 10: 262-267. (Pubitemid 28174769)
10. Luyendyk, J.P., G.A. Schabbauer, M. Tencati, et al. 2008. Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages. Journal of Immunology 180: 4218-4226.
11. Kyriakis, J.M., and J. Avruch. 2001. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiological Reviews 81: 807-869. (Pubitemid 32267078)
12. Kim, H.J., H.S. Lee, Y.H. Chong, et al. 2006. P38 mitogen-activated protein kinase up-regulates LPS-induced NF-kappa B activation in the development of lung injury and RAW 264.7 macrophages. Toxicology 225: 36-47. (Pubitemid 44026641)
13. Mulsch, A., B. Schray-utz, P.I. Mordvintcev, et al. 1993. Diethyldithiocarbamate inhibits induction of macrophage NO synthase. FEBS Letters 321: 215-218. (Pubitemid 23114080)
14. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annual Review of Immunology 18: 621-663. (Pubitemid 30365393)
15. Levy, R.M., K.P. Mollen, J.M. Prince, et al. 2007. Systemic inflammation and remote organ injury following trauma require HMGB1. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 293: R1538-1544. (Pubitemid 47535772)
16. DiDonato, J.A., M. Hayakawa, D.M. Rothwarf, et al. 1997. A cytokine-responsive IkB kinase that activates the transcription factor NF-kB. Nature 388: 548-554. (Pubitemid 27339997)
17. Kim, J.Y., and S.M. Lee. 2005. Effect of alpha-tocopherol on the expression of hepatic vascular stress genes in response to sepsis. Journal of Toxicology and Environmental Health. Part A 68: 2051-2062.
18. Erdem, A., A.M. Sevgili, F. Akbiyik, et al. 2008. The effect of taurine on mesenteric blood flow and organ injury in sepsis. Amino Acids 35: 403-410.
19. Biolo, G., R. Antonione, and M. De Cicco. 2007. Glutathione metabolism in sepsis. Critical Care Medicine 35: S591-595. (Pubitemid 47312200)
20. Hagiwara, S., H. Koga, H. Iwasaka, et al. 2010. ETS-GS, a new antioxidant, ameliorates renal ischemia-reperfusion injury in a rodent model. J Surg Res. doi:10.1016/j.jss.2010.01.039.
21. Murakami, K., R. McGuire, R.A. Cox, et al. 2002. Heparin nebulization attenuates acute lung injury in sepsis following smoke inhalation in sheep. Shock 18: 236-241.
22. Hotchkiss, R.S., P.E. Swanson, B.D. Freeman, et al. 1999. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Critical Care Medicine 27: 1230-1251. (Pubitemid 29379358)
23. Nasraway, S.A. 2003. The problems and challenges of immunotherapy in sepsis. Chest 123: S451-459.
24. Wheeler, D.S., B. Zingarelli, W.J. Wheeler, et al. 2009. Novel pharmacologic approaches to the management of sepsis: targeting the host inflammatory response. Recent Patents on Inflammation & Allergy Drug Discovery 3: 96-112.
25. Hagiwara, S., H. Iwasaka, S. Matsumoto, et al. 2010. In vivo and in vitro effects of the anticoagulant, thrombomodulin, on the inflammatory response in rodent models. Shock 33: 282-288.
26. Hagiwara, S., H. Iwasaka, S. Matsumoto, et al. 2008. High dose antithrombin III inhibits HMGB1 and improves endotoxin-induced acute lung injury in rats. Intensive Care Medicine 34: 361-367. (Pubitemid 351207646)
27. Kramer, H.F., and L.J. Goodyear. 2007. Exercise, MAPK, and NF-kappaB signaling in skeletal muscle. Journal of Applied Physiology 103: 388-395. (Pubitemid 47092316)
28. Savoia, C., and E.L. Schiffrin. 2006. Inflammation in hypertension. Current Opinion in Nephrology and Hypertension 15: 152-158.
29. Diaz-Guerra, M.J., A. Castrillo, P. Martin-Sanz, et al. 1999. Negative regulation by phosphatidylinositol 3-kinase of inducible nitric oxide synthase expression in macrophages. Journal of Immunology 162: 6184-6190. (Pubitemid 29314981)
30. Ci, X., R. Ren, K. Xu, et al. 2010. Schisantherin A exhibits anti-inflammatory properties by down-regulating NF-kappaB and MAPK signaling pathways in lipopolysaccharide-treated RAW 264.7 cells. Inflammation 33: 126-136.